NovoCure Limited (United States) is listed on the Nasdaq and has a market capitalization of $1.29 billion, with shareholders equity totaling $350.61 million.
The company employs approximately 1.023 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, NovoCure Limited reported $725.39 million in revenue, generating net income of $-121.73 million.
Key financial metrics include a P/E ratio of -10.60, a price-to-book (P/B) ratio of 3.68, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker NVCR.